AU2001296301A8 - Nucleic acids, proteins, and antibodies - Google Patents

Nucleic acids, proteins, and antibodies

Info

Publication number
AU2001296301A8
AU2001296301A8 AU2001296301A AU2001296301A AU2001296301A8 AU 2001296301 A8 AU2001296301 A8 AU 2001296301A8 AU 2001296301 A AU2001296301 A AU 2001296301A AU 2001296301 A AU2001296301 A AU 2001296301A AU 2001296301 A8 AU2001296301 A8 AU 2001296301A8
Authority
AU
Australia
Prior art keywords
antibodies
proteins
nucleic acids
nucleic
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296301A
Inventor
Craig A Rosen
Charles E Birse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2001296301A8 publication Critical patent/AU2001296301A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
AU2001296301A 2000-09-26 2001-09-25 Nucleic acids, proteins, and antibodies Abandoned AU2001296301A8 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23548400P 2000-09-26 2000-09-26
PCT/US2001/029838 WO2002026930A2 (en) 2000-09-26 2001-09-25 Nucleic acids, proteins, and antibodies

Publications (1)

Publication Number Publication Date
AU2001296301A8 true AU2001296301A8 (en) 2009-07-30

Family

ID=22885694

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001296301A Abandoned AU2001296301A8 (en) 2000-09-26 2001-09-25 Nucleic acids, proteins, and antibodies
AU2001296301A Abandoned AU2001296301A1 (en) 2000-09-26 2001-09-25 Nucleic acids, proteins, and antibodies

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001296301A Abandoned AU2001296301A1 (en) 2000-09-26 2001-09-25 Nucleic acids, proteins, and antibodies

Country Status (2)

Country Link
AU (2) AU2001296301A8 (en)
WO (1) WO2002026930A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140937A0 (en) 1998-08-07 2002-02-10 Immunex Corp Molecules designated ldcam
SG145559A1 (en) * 2002-06-06 2008-09-29 Oncotherapy Science Inc Genes and polypeptides relating to human colon cancers
EP2133362B1 (en) 2003-07-25 2012-04-18 Amgen, Inc Methods relating to LDCAM and CRTAM
WO2005059504A2 (en) * 2003-12-12 2005-06-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor gpr34 (gpr34)
US8415455B2 (en) * 2007-09-04 2013-04-09 Compugen Ltd Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
US8871737B2 (en) 2010-09-22 2014-10-28 Alios Biopharma, Inc. Substituted nucleotide analogs
EP2726503B1 (en) 2011-06-30 2019-09-04 Compugen Ltd. Polypeptides and uses thereof for treatment of autoimmune disorders and infection
WO2013096680A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
WO2013114367A2 (en) 2012-02-01 2013-08-08 Compugen Ltd. C10rf32 antibodies, and uses thereof for treatment of cancer
EP2828277A1 (en) 2012-03-21 2015-01-28 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
SI3124976T1 (en) * 2015-07-28 2018-12-31 F. Hoffmann-La Roche Ag Improved bacterial endotoxin test for the determination of endotoxins

Also Published As

Publication number Publication date
WO2002026930A3 (en) 2009-06-11
AU2001296301A1 (en) 2002-04-08
WO2002026930A9 (en) 2005-04-07
WO2002026930A2 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU4313701A (en) Nucleic acids, proteins, and antibodies
AU5077101A (en) Nucleic acids, proteins, and antibodies
AU2001296301A8 (en) Nucleic acids, proteins, and antibodies
AU3095801A (en) Nucleic acids, proteins, and antibodies
AU2001229508A1 (en) Nucleic acids, proteins, and antibodies
AU2001236466A8 (en) Nucleic acids, proteins, and antibodies
AU6289901A (en) Nucleic acids, proteins, and antibodies
AU3795301A (en) Nucleic acids, proteins, and antibodies
AU3646001A (en) Nucleic acids, proteins, and antibodies
AU2001252878A8 (en) Nucleic acids, proteins, and antibodies
AU5287801A (en) Nucleic acids, proteins, and antibodies
AU2001241403A1 (en) Nucleic acids, proteins, and antibodies
AU2001230958A1 (en) Nucleic acids, proteins, and antibodies
AU2001237948A1 (en) Nucleic acids, proteins, and antibodies
AU2001236460A1 (en) Nucleic acids, proteins, and antibodies
AU2001239728A1 (en) Nucleic acids, proteins, and antibodies
AU2001239726A1 (en) Nucleic acids, proteins, and antibodies
AU2001237953A1 (en) Nucleic acids, proteins, and antibodies
AU2001237946A1 (en) Nucleic acids, proteins, and antibodies

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase